ADMA Biologics, Inc. Provides Earnings Guidance for the Fiscal Year 2022 and 2024
For the year 2024, the company expects $250 million or more in topline revenue in 2024, net income in the range of $50 million - $100 million during the 2024-2025 time period and beyond.